Pictet Asset Management (UK)’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $3.06M | Buy |
210,644
+35,351
| +20% | +$513K | ﹤0.01% | 933 |
|
|
2021
Q1 | $3.58M | Buy |
175,293
+111,165
| +173% | +$2.27M | ﹤0.01% | 895 |
|
|
2020
Q4 | $1.14M | Hold |
64,128
| – | – | ﹤0.01% | 994 |
|
|
2020
Q3 | $948K | Buy |
+64,128
| New | +$948K | ﹤0.01% | 966 |
|
|
2018
Q3 | – | Sell |
-75,900
| Closed | -$1.72M | – | 958 |
|
|
2018
Q2 | $1.72M | Sell |
75,900
-45,500
| -37% | -$1.03M | ﹤0.01% | 816 |
|
|
2018
Q1 | $2.94M | Buy |
+121,400
| New | +$2.94M | 0.01% | 755 |
|
|
2016
Q4 | – | Sell |
-57,074
| Closed | -$2.07M | – | 864 |
|
|
2016
Q3 | $2.07M | Hold |
57,074
| – | – | 0.01% | 728 |
|
|
2016
Q2 | $1.31M | Sell |
57,074
-22,826
| -29% | -$525K | 0.01% | 777 |
|
|
2016
Q1 | $1.26M | Hold |
79,900
| – | – | 0.01% | 741 |
|
|
2015
Q4 | $1.31M | Buy |
79,900
+26,000
| +48% | +$426K | 0.01% | 767 |
|
|
2015
Q3 | $592K | Buy |
+53,900
| New | +$592K | ﹤0.01% | 822 |
|
|
2014
Q3 | – | Sell |
-34,970
| Closed | -$1.12M | – | 883 |
|
|
2014
Q2 | $1.12M | Buy |
+34,970
| New | +$1.12M | 0.01% | 783 |
|